MedPath

Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2

Phase 3
Completed
Conditions
Diabetes Mellitus
Local Anesthesia
Interventions
Drug: L+C maxillary anesthesia
Drug: L+C mandibular anesthesia
Drug: L+E maxillary anesthesia
Drug: L+E mandibular anesthesia
Registration Number
NCT02371759
Lead Sponsor
University of Belgrade
Brief Summary

The purpose of this study is to determine whether 2% lidocaine (L) + clonidine (C) (15 mcg/ml) as a vasoconstrictor achieves efficient (equal or better parameters of intraoral local anesthesia in comparison to 2% lidocaine + epinephrine (E) (1:80 000)) and safe (stable cardiovascular parameters - systolic, diastolic, mean blood pressure and heart rate) intraoral local anesthesia in patients with Diabetes mellitus type 2.

Detailed Description

Patients with diabetes mellitus type 2, represent a risk for performing regional anesthesia techniques due to microvascular (microangiopathy, neuropathy) and macrovascular (hypertension, coronary heart disease) complications. There is evidence that local anesthetic toxicity may be increased in diabetic setting due to underlying neuropathy; while interaction of diabetic blood vessels with vasoconstrictors may be of importance because of microangiopathic changes. Lately, regional anesthesia protocol in general surgery for patients with diabetes mellitus was released, proposing reduction of local anesthetic concentration and avoiding epinephrine as vasoconstrictor.

Oral cavity tissues in diabetes mellitus also suffer from neuropathy (burning, paresthesia, teeth loss, temporomandibular dysfunction, xerostomia) and microangiopathy (periodontal disease, salivary gland dysfunction). Most widely used vasoconstrictor for intraoral local anesthesia, epinephrine, is an alpha- and beta- adrenergic agonist. Because of its beta-adrenergic effects, epinephrine could adversely affect cardiovascular function, especially in risk patients. There are data suggesting that intraoral local anesthesia obtained with 2% lidocaine with clonidine, selective alpha 2-adrenoceptor agonist as a vasoconstrictor, is characterized with significantly more stable cardiovascular parameters and similar parameters of local anesthesia with respect to lidocaine with epinephrine in healthy and hypertensive patients.

With regard to aforementioned, the aim of this randomized double-blind controlled clinical trial is to evaluate and compare efficacy and safety of intraoral local anesthesia obtained with 2% lidocaine (L) + clonidine (15 mcg/ml) (C) or 2% L + epinephrine (1:80 000) (E), comparing healthy and diabetes mellitus type 2 patients. Prior to tooth extraction, random allocation to one of four groups (L+C maxillary infiltration, L+C mandibular block, L+E maxillary infiltration and L+E mandibular block) is performed for diabetic (30 per group) and healthy (30 per group) patients. Parameters of local anesthesia (onset, duration, intensity, width of anesthetic field for maxillary infiltration), cardiovascular parameters (systolic, diastolic, mean arterial pressure; heart rate and electrocardiographic changes), quality of postoperative analgesia (assessed by Visual Analogue Scale, Numerical Rating Scale and number of consumed analgesics) and postoperative complications (infection, bleeding, paresthesia, delayed wound healing) are evaluated and compared.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
256
Inclusion Criteria
  • Healthy participants: ASA I
  • Diabetic type 2 participants: ASA III (HbA1c level < 9%)
  • Required a single-root teeth indicated for non-complicated extraction
  • Dental diagnosis of periodontal disease, tooth fracture, chronic periapical lesion and root infection
  • Subjects give informed written consent
Read More
Exclusion Criteria
  • Pregnancy and lactation
  • Allergy to used drugs and food
  • Hepatic and/or renal failure
  • ASA IV patients
  • Tobacco smokers
  • History of alcoholism and/or drug abuse and addiction
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diabetics: L+C maxillary anesthesiaL+C maxillary anesthesiaSingle dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for maxillary infiltration anesthesia
Diabetics: L+C mandibular anesthesiaL+C mandibular anesthesiaSingle dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for mandibular block anesthesia
Diabetics: L+E maxillary anesthesiaL+E maxillary anesthesiaSingle dose intraoral local anesthesia with 2ml lidocaine (2%)+ epinephrine (1:80.000) for maxillary infiltration anesthesia
Diabetics: L+E mandibular anesthesiaL+E mandibular anesthesiaSingle dose intraoral local anesthesia with 2ml lidocaine (2%) + epinephrine (1:80.000) for mandibular block anesthesia
Healthy: L+C maxillary anesthesiaL+C maxillary anesthesiaSingle dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for maxillary infiltration anesthesia
Healthy: L+C mandibular anesthesiaL+C mandibular anesthesiaSingle dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for mandibular block anesthesia
Healthy: L+E maxillary anesthesiaL+E maxillary anesthesiaSingle dose intraoral local anesthesia with 2ml lidocaine (2%)+ epinephrine (1:80.000) for maxillary infiltration anesthesia
Healthy: L+E mandibular anesthesiaL+E mandibular anesthesiaSingle dose intraoral local anesthesia with 2ml lidocaine (2%) + epinephrine (1:80.000) for mandibular block anesthesia
Primary Outcome Measures
NameTimeMethod
Baseline Systolic Blood PressureBaseline, 0 minutes
Duration of Intraoral Local AnesthesiaUp to 6 hours after local anesthesia injection

Time until cessation in soft tissue numbness

Intensity of Intraoral Local AnesthesiaUp to 10 minutes after local anesthesia injection

Number of participants who reported values \> 0 after pin-prick testing, using Visual Analogue Scale (VAS) and Numerical Rating Scale (NRS). VAS is represented by line 100 mm long, with one end marked with 0 and words "no pain" , while the other end is marked with 100 and words "the worst pain imanginable". VRS scale is represented by line 100 mm long, marked with numbers from 0 to 10, where 0 corresponds to "no pain", and 10 corresponds to "the worst pain imaginable". For both scales, higher scores represent worse outcomes.

Systolic Blood Pressure at 10 Minutes10th minute

Systolic blood pressure values 5 minutes after local anesthesia injection

Baseline Diastolic Blood Pressurebaseline, 0 minutes
Diastolic Blood Pressure at 15 Minutes15th minute

Diastolic blood pressure values 10 minutes after local anesthesia injection

Diastolic Blood Pressure at 20 Minutes20th minute

Diastolic blood pressure values 15 minutes after local anesthesia injection

Diastolic Blood Pressure at 35 Minutes35th minute

Diastolic blood pressure values 30 minutes after local anesthesia injection

Baseline Values of Heart Ratebaseline, 0 minutes
Heart Rate at 20 Minutes20th minute

Heart rate 15 minutes after local anesthesia injection, 20 minutes after baseline measurement

Systolic Blood Pressure at 15 Minutes15th minute

Systolic blood pressure values 10 minutes after local anesthesia injection

Diastolic Blood Pressure at 10 Minutes10th minute

Diastolic blood pressure values 5 minutes after local anesthesia injection

Heart Rate at 10 Minutes10th minute

Heart rate 5 minutes after local anesthesia injection, 10 minutes after baseline measurement

Systolic Blood Pressure at 35 Minutes35th minute

Systolic blood pressure values 30 minutes after local anesthesia injection

Electrocardiogram at 15 Minutes15th minute

ECG 10 minutes after local anesthesia injection, 15 minutes after baseline measurement

Systolic Blood Pressure at 20 Minutes20th minute

Systolic blood pressure values 15 minutes after local anesthesia injection

Heart Rate at 15 Minutes15th minute

Heart rate 10 minutes after local anesthesia injection, 15 minutes after baseline measurement

Ceart Rate at 35 Minutes35th minute

Heart rate 30 minutes after local anesthesia injection, 35 minutes after baseline measurement

Electrocardiogram at 10 Minutes10th minute

ECG 5 minutes after local anesthesia injection, 10 minutes after baseline measurement

Baseline Electrocardiogrambaseline, 0 minutes
Electrocardiogram at 20 Minutes20th minute

ECG 15 minutes after local anesthesia injection, 20 minutes after baseline measurement

Secondary Outcome Measures
NameTimeMethod
Local Postoperative Complications24 hours, 7 days

Postoperative paresthesia by clinical examination

Onset of Intraoral Local AnesthesiaUp to 10 minutes, until subjective feeling of soft tissue numbnes

Evaluated by pin-prick after subjective feeling of soft tissue numbness appeared after local anesthesia injection

Width of Anesthetic Field After Maxillary Infiltration AnesthesiaUp to 10 minutes after injection of local anesthesia

Soft tissue numbness area determined by pin-prick test after maxillary infiltration anesthesia. Not tested for mandibular ablock anesthesia.

Postoperative Analgesiaup to 24 hours after tooth extraction

Number of participants who experienced postoperative pain, VAS, NRS

Trial Locations

Locations (1)

School of Dental Medicine, University of Belgrade

🇷🇸

Belgrade, Serbia

© Copyright 2025. All Rights Reserved by MedPath